Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates

Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of$ 0.08 per share. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 62.50%. A quarter ago, it was expected that this medical technology company would post a loss of$ 0.05 per share when it actually produced a loss of $0.38, delivering a surprise of -660%.Over the last f ...